 - Myelosuppressive chemotherapy: Must not have received within 28 days of entry onto this study 42 days if prior nitrosourea accompanied by hematopoietic recovery, or 14 days of stopping non-myelosuppressive therapy as long as hematopoietic requirements are met; 